NCT05190185 - A Clinical Trial of TAA06 Injection in Advanced Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

December 1, 2023

Study Completion Date

December 1, 2023

Conditions

Malignant Melanoma, Lung Cancer, or Colorectal Cancer

Interventions

BIOLOGICAL

TAA06 injection

The subjects, who sign the informed consent forms and been screened by inclusion/exclusion criteria, will be treated with 1×106\~1×108 CAR-T/kg. And the subjects will be administered once.

Trial Locations (1)

215125

RECRUITING

PersonGen BioTherapeutics(Suzhou) Co., Ltd., Suzhou